Home / Mesalazine / Japan
JP ATC A07EC02 · updated 2 Nov 2026
Mesalazine shortage in Japan
Is there a Mesalazine shortage in Japan?
Yes. As of 2 Nov 2026, 11 Mesalazine products are reported short in Japan, the first since 12 May 2023. No return date has been given. Main reason: increased demand.
Also short in Canada, Germany, France, Ireland, Austria, Czechia, Norway, Sweden, New Zealand, Australia. All countries.
Affected products in Japan
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| JP | メサラジン徐放錠250mg「日医工P」 limited | Nichi-Iko | 12 May 2023 | not given | Increased demand |
| JP | メサラジン徐放錠500mg「日医工P」 limited | Nichi-Iko | 12 May 2023 | not given | Increased demand |
| JP | メサラジン腸溶錠400mg「サワイ」 limited | Sawai | 16 Oct 2024 | not given | Increased demand |
| JP | ペンタサ坐剤1g limited | フェリング・ファーマ | 31 Jul 2025 | not given | Quality problem or recall Quality problem |
| JP | ペンタサ錠250mg limited | フェリング・ファーマ | 19 Dec 2025 | not given | Other |
| JP | ペンタサ錠500mg limited | フェリング・ファーマ | 19 Dec 2025 | not given | Other |
| JP | ペンタサ顆粒94% limited | フェリング・ファーマ | 19 Dec 2025 | not given | Other |
| JP | メサラジン徐放錠500mg「トーワ」 | Towa (Pensa) | 9 Jul 2026 | not given | Quality problem or recall Quality problem |
| JP | メサラジン錠250mg「ケミファ」 limited | 日本ケミファ | 27 Jul 2026 | not given | Manufacturing problem |
| JP | メサラジン錠500mg「ケミファ」 limited | 日本ケミファ | 27 Jul 2026 | not given | Manufacturing problem |
| JP | メサラジン徐放錠250mg「トーワ」 | Towa (Pensa) | 30 Oct 2026 | not given | Manufacturing problem |
Source
MHLW (Ministry of Health, Labour and Welfare), supply status of prescription medicines. Official list. Prescription products under limited shipment or supply suspension (delistings excluded); one row per product.